Welcome to the CCRII (Chicago Clinical Research Institute, Inc.) blog! CCRII Blog is our most used communication channel where we as a team of multi-specialty dedicated research facility share research results of phase II to phase IV clinical trials.
We all know that modern medicine is constantly evolving, but despite the vast knowledge about diseases and available drugs, we are still not able to effectively treat some diseases. This is the reason why it is extremely important to search for new substances and how to use them, which may bring researchers closer to inventing drugs for many so far incurable diseases. These substances are discovered and tested through many years of laboratory experiments and trials on experimental animals. Those substances with the greatest hope for effective use in the fight against disease are subjected to human trials, i.e. clinical trials.
Clinical trials of drugs are not only the domain of large pharmaceutical companies. Very often, physicians for research purposes create their own research protocols to, for example, evaluate the effectiveness of alternative treatments. They publish their results in scientific journals and at congresses.
Advances in medicine, the development of many new drugs and therapies – have allowed us to deal with many diseases that until recently were considered incurable. Over the past 20 years, scientists have discovered and developed over 300 new drugs, vaccines, and medical products that have been marketed to help treat more than 150 different diseases. These are some examples of breakthroughs in medicine in recent years. None of them would be possible without clinical trials:
In 1999, only 3 in 10 patients diagnosed with leukemia survived to 5 years. Today, in many cases, treatment is effective and stops the progression of the disease or even completely cures it.
In 1995, thanks to the development of protease inhibitors and subsequent research into improving drugs and therapies, the death rate among AIDS patients fell by 70%.
12 years ago, there was no medicine that would effectively counteract the development of Alzheimer’s disease. Today, three different classes of drugs are available to slow the progression of the disease and relieve its symptoms.
Until the early 1960s, patients who required internal organ transplantation had a relatively low chance of success. Very few transplants from unrelated donors were accepted. Today, thanks to new drugs, transplant rejection is becoming less and less frequent.
Even 50 years ago, polio disease caused great fear because it was associated with a high risk of death. Thanks to the invention of the vaccine, it has been successfully contained in most regions of the world. The World Health Organization (WHO) announced in 2002 that Europe was free from this disease.
This all throws light on the importance of clinical research and here through this blog, we keep you all updated with the researches we take on and their results. To stay tuned in, subscribe to our newsletter and get the latest updates all the time.